Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Olema selloff on AstraZeneca miss a buying opportunity, says Citi

businessinsider

Sep 14, 2026 at 05:30 AM

Olema selloff on AstraZeneca miss a buying opportunity, says Citi

Login to unlock65characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
Nov 11, 2025 at 01:51 PMConsolidating its position as the "largest heavyweight stock" in the UK market, pharmaceutical giant Astrazeneca's stock…
Jul 29, 2025 at 07:44 AMStrong sales of anti-cancer drugs, AstraZeneca's Q2 revenue increased by 12% year-on-year, exceeding expectations | Fina…

Related Stocks

Olema Pharmaceuticals

USOLMA

+0.68%

AstraZeneca

USAZN

+2.25%

LongbridgeAI